To exploit the exploitation of actin by HIV?

Author： Yeung K.-S.   Yamanaka G.A.  

Publisher： Elsevier

ISSN： 1359-6446

Source： Drug Discovery Today, Vol.9, Iss.1, 2004-01, pp. : 2-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Subversion of chemokine receptors by HIV: how can we exploit this?

By Pakianathan D.R.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 7, 1997-07 ,pp. : 841-846

Informa Healthcare

Access to resources Recommend Favorite

Telomerase - strategies to exploit an important chemotherapeutic target

By Fletcher Terace M  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 3, 2001-06 ,pp. : 363-378

Informa Healthcare

Access to resources Recommend Favorite

Baculovirus Infectivity and the Actin Cytoskeleton

By  

Current Drug Targets, Vol. 8, Iss. 10, 2007-10 ,pp. : 1075-1083

Bentham Science Publishers

Access to resources Recommend Favorite

F-actin levels but not actin polymerization are affected by triphenyltin in HL-60 cells

By Turvey G.J.   Marinovich M.   Guizzetti M.   Grazi E.   Trombetta G.   Galli C.L.  

Environmental Toxicology and Pharmacology, Vol. 1, Iss. 1, 1996-02 ,pp. : 13-20

Elsevier

Access to resources Recommend Favorite

Actin-Associated Proteins in Ameloblast Differentiation

By  

Cells Tissues Organs, Vol. 171, Iss. 2-3, 2002-06 ,pp. : 128-134

Karger

Access to resources Recommend Favorite